Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

With the recent approval of highly effective coronavirus disease 2019 (COVID-19) vaccines, functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently under investigation as antibody levels in plasma were shown to decline during convalescence. Since t...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Sai Priya, Prévost, Jérémie, Nayrac, Manon, Beaudoin-Bussières, Guillaume, Benlarbi, Mehdi, Gasser, Romain, Brassard, Nathalie, Laumaea, Annemarie, Gong, Shang Yu, Bourassa, Catherine, Brunet-Ratnasingham, Elsa, Medjahed, Halima, Gendron-Lepage, Gabrielle, Goyette, Guillaume, Gokool, Laurie, Morrisseau, Chantal, Bégin, Philippe, Martel-Laferrière, Valérie, Tremblay, Cécile, Richard, Jonathan, Bazin, Renée, Duerr, Ralf, Kaufmann, Daniel E., Finzi, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097665/
https://www.ncbi.nlm.nih.gov/pubmed/33969322
http://dx.doi.org/10.1016/j.xcrm.2021.100290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097665/
https://www.ncbi.nlm.nih.gov/pubmed/33969322
http://dx.doi.org/10.1016/j.xcrm.2021.100290

Ejemplares similares